Android app on Google Play

Hemispherx Biopharma (HEB) Doubles Q1 Loss to 2c/Share

May 7, 2012 4:36 PM EDT Send to a Friend
Hemispherx Biopharma, Inc. (NYSE: HEB) reported Q1 EPS of ($0.02), versus ($0.01) reported last year.

For earnings history and earnings-related data on Hemispherx Biopharma, Inc. (HEB) click here.

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment